Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Merck Kgaa ADR
(OP:
MKKGY
)
36.98
-0.31 (-0.83%)
Streaming Delayed Price
Updated: 3:51 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
32,276
Open
37.02
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
37.29
Today's Range
36.87 - 37.02
52wk Range
28.59 - 38.26
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Pfizer Clears Required Regulatory Hurdles To Complete $43B Seagen Acquisition
December 12, 2023
Pfizer Inc (NYSE: PFE)
Via
Benzinga
Merck Germany's Two Pivotal Trials Flunk In Multiple Sclerosis
December 06, 2023
Merck KGaA (OTC: MKGAF) (OTC:
Via
Benzinga
Performance
YTD
+18.87%
+18.87%
1 Month
+12.50%
+12.50%
3 Month
+2.41%
+2.41%
6 Month
+11.12%
+11.12%
1 Year
+6.85%
+6.85%
More News
Read More
Life Sciences Player Repligen's Strategic European Acquisition - What It Means for Investors
September 26, 2023
Via
Benzinga
Merck Germany Reports 5% Decline In Q2 Sales, Expects More Decline In 2023
August 03, 2023
Via
Benzinga
Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List
July 26, 2023
Via
Benzinga
Germany's Merck To Launch Semiconductor Base In China
May 31, 2022
Via
Benzinga
Abcam Downgrade: Analyst Trims Expectations Amid Activist Investor Engagement and Potential Bid Anticipation
June 20, 2023
Via
Benzinga
Analyst Says Nektar Therapeutics' Rezpeg Prioritization Likely to Spark Investor Questions
April 18, 2023
Via
Benzinga
FDA Issues Partial Clinical Hold On Merck Germany's Multiple Sclerosis Study
April 12, 2023
Via
Benzinga
Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
March 27, 2023
Via
Benzinga
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval
March 23, 2023
Via
Benzinga
With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
January 20, 2023
Via
Benzinga
PDS Biotech, Merck Germany Enter Licensing Pact For Investigational Cancer Treatment
January 03, 2023
Via
Benzinga
Mersana Inks Cancer Therapy Development Deal With Merck Germany
December 23, 2022
Via
Benzinga
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
October 19, 2022
Via
Benzinga
Germany's Merck Slapped With Formal French Investigation Related To Its Thyroid Drug
October 19, 2022
Via
Benzinga
PDS Biotech Highlights Expanded Data From PDS0101 Triple Combination Trial In HPV-Positive Cancers
October 11, 2022
Via
Benzinga
TSM Looks To Hire Over 8,000 People In 2022
January 24, 2022
Via
Benzinga
Despite Palantir’s Impressive Deals, Its Losses and Valuation Make It Unappetizing
January 21, 2022
Via
InvestorPlace
The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings
November 18, 2021
Via
Benzinga
GlaxoSmithKline, Merck KGaA End $4B Cancer Drug Pact
September 30, 2021
Via
Benzinga
Nektar, Merck Germany, Pfizer Join Forces For Mid-Stage Bladder Cancer Study
September 21, 2021
Via
Benzinga
Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
August 24, 2021
Via
Benzinga
Sutro Biopharma Receives Undisclosed Milestone Payment Under Bispecific ADC Collaboration with Merck
June 01, 2021
Via
Benzinga
Immutep, Merck Germany Team Up for Eftilagimod/Bintrafusp Combo Trial In Solid Tumors
June 01, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.